HEMOSOL

This brand name is authorized in Croatia, Estonia, Finland, France, Ireland, Lithuania, New Zealand, South Africa, Spain, UK.

Active ingredients

The drug HEMOSOL contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 451W47IQ8X - SODIUM CHLORIDE
 

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

 
Read more about Sodium chloride
2
UNII 8MDF5V39QO - SODIUM BICARBONATE
 

Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide.

 
Read more about Sodium bicarbonate
3
UNII M4I0D6VV5M - CALCIUM CHLORIDE
 

Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat.

 
Read more about Calcium chloride
4
UNII 02F3473H9O - MAGNESIUM CHLORIDE
 
Read more about Magnesium chloride
5
UNII 33X04XA5AT - LACTIC ACID, UNSPECIFIED FORM
 
Read more about Lactic acid

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 HEMOSOL B0 Solution for haemodialysis / haemofiltration MPI, EU: SmPC Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B05ZB Hemofiltrates B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05Z Hemodialytics and hemofiltrates
Discover more medicines within B05ZB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1421424
ES Centro de información online de medicamentos de la AEMPS 62900
FI Lääkealan turvallisuus- ja kehittämiskeskus 048770
FR Base de données publique des médicaments 61475677
GB Medicines & Healthcare Products Regulatory Agency 325120
HR Agencija za lijekove i medicinske proizvode HR-H-037692627
LT Valstybinė vaistų kontrolės tarnyba 1038226
NZ Medicines and Medical Devices Safety Authority 14426
ZA Health Products Regulatory Authority 50/32.11/1074

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.